Table 2 Patient, disease and treatment demographics

From: The role of folate receptor alpha (FRα) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy

Parameters

n (%)

Median age, range

65.6, 49–82

Gender

 

 Male/Female

49 (79)/13 (21)

Histology

 

 Epithelioid

36 (58)

 Biphasic

17 (27)

 Sarcomatoid

9 (15)

Stage

 

 1/2/3/4

4 (6)/16 (26)/32 (52)/10 (16)

WHO PS

 

 0/1/2

8 (13)/36 (58)/18 (29)

Chemotherapy regimen

 

 Pemetrexed/Carboplatin

45 (73)

 Pemetrexed/Cisplatin

12 (27)

Median chemotherapy cycles (range)

4 (2–6)